Skip to main content
Back to Quiet Capital

Quiet Capital's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Quiet Capital. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$267.5M

Pharmaceutical Portfolio Companies (5)

Export
BiotechnologyHealth CarePharmaceutical

Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.

New York, United States
January 2025
$14.0M
Series A

Founder Contacts

41,000+ verified contacts

ChemicalIndustrial AutomationIndustrial ManufacturingManufacturingOil and GasPharmaceuticalPredictive AnalyticsSoftware

Basetwo is an AI CoPilot for manufacturing that provides engineers with recommendations on how to optimize yield, quality, and costs.

Toronto, Canada
January 2025
$11.5M
Series A

Founder Contacts

41,000+ verified contacts

Health CareMedicalmHealthPharmaceutical

Truepill provides an API-connected healthcare infrastructure designed to revolutionize the patient experience.

Hayward, United States
October 2021
$142.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyPetPharmaceuticalVeterinary

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

San Francisco, United States
February 2026
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical

Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.

Palo Alto, United States
January 2021
Series B

Founder Contacts

41,000+ verified contacts

Explore Quiet Capital's Full Portfolio

View all companies funded by Quiet Capital across every industry and funding stage.

View Full Quiet Capital Portfolio